FDA tentatively approves generic AIDS drug

Share this article:
The FDA granted tentative approval to the generic drug lamivudine for pediatric patients with HIV.
As such, lamivudine will be available for purchase outside the U.S. under President Bush's Emergency Plan for AIDS Relief, a $15-billion plan to provide treatment and palliative care to patients with HIV/AIDS over five years and prevent new cases among 15 of the hardest hit countries.
The drug will be manufactured by Hyderabad, India concern Aurobindo Pharma LTD.
The FDA action marks the first generic version of Epivir Oral Solution, manufactured by GlaxoSmithKline. If the generic were to gain full approval, it would become the second non-branded AIDS treatment.
Another generic antiretroviral drug product, didanosine from Barr Laboratories, has full approval for U.S marketing.
The agency said its tentative approval means that, although existing patents and/or exclusivity prevent U.S. marketing of the drug, lamivudine meets FDA safety, efficacy, and manufacturing quality standards required for sales in the U.S.
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.